Invention Grant
- Patent Title: RNA-guided endonuclease fusion polypeptides and methods of use thereof
-
Application No.: US16641950Application Date: 2018-09-06
-
Publication No.: US11649442B2Publication Date: 2023-05-16
- Inventor: Schaked Omer Halperin
- Applicant: The Regents of the University of California
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Bozicevic, Field & Francis LLP
- Agent Paula A. Borden
- International Application: PCT/US2018/049766 2018.09.06
- International Announcement: WO2019/051097A 2019.03.14
- Date entered country: 2020-02-25
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N9/12 ; C12N9/78 ; C12N15/10 ; C12N15/11

Abstract:
The present disclosure provides a fusion polypeptide comprising: a) an enzymatically active RNA-guided endonuclease that introduces a single-stranded break in a target DNA; and b) an error-prone DNA polymerase. The present disclosure provides a system comprising: a) a fusion polypeptide of the present disclosure; and b) a guide RNA. The present disclosure provides a cell comprising a fusion polypeptide of the present disclosure, or a system of the present disclosure. The present disclosure provides a method of mutagenizing a target polynucleotide.
Public/Granted literature
- US20200248155A1 RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USE THEREOF Public/Granted day:2020-08-06
Information query